Apollo is likely to report a strong improvement in margins, to ~15.2%, driven by traction across segments. New hospital addition would boost KIMS’ revenue growth by ~27%, though may dent margins by 887bps YoY to ~20%.
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Hospitals under our coverage are likely to report revenue/Ebitda/PAT growth of 15.1%/14.3%/10.8% YoY in Q2 FY26, driven by better occupancy (rise of 20-240bps across coverage) coupled with an improved surgical mix.
Apollo is likely to report a strong improvement in margins, to ~15.2%, driven by traction across segments. New hospital addition would boost KIMS’ revenue growth by ~27%, though may dent margins by 887bps YoY to ~20%.
Other hospitals under coverage shall post a modest expansion in margins, between 25–63bps. Diagnostic companies under our coverage are likely to report growth of 16.4%/15.4%/22.3% YoY in revenue/Ebitda/PAT, mainly driven by volume growth of 9–17% supported by merger and acquisition and lab expansion in smaller towns.
Our top picks in healthcare services are Apollo Hospitals, Jupiter LifeLine and Metropolis.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.